Enzyme research points to better drugs and improved industrial processes

Groundbreaking research on enzymes could revolutionise the way drugs are made and have major implications for the industrial sector, say its authors.

The University of Manchester team, working with colleagues in Bristol, has provided a unique insight into the working of enzymes - biological molecules that speed up chemical reactions in the body.

When these chemical reactions go wrong they can lead to disease, so modern drugs are designed to target enzymes and 'switch them off'.

But their ability to accelerate chemical reactions means enzymes are also used in a number of commercial processes, including brewing, food processing, domestic cleaning and paper manufacturing.

"Improving our fundamental knowledge of how enzymes work is important to a wide range of pharmaceutical and industrial fields," said Professor Nigel Scrutton, one of the lead researchers at Manchester.

"Enzymes are central to the existence of life because most chemical reactions in our cells would take place too slowly or produce a different outcome without their involvement.

"But when enzymes malfunction they can cause serious diseases, so modern drugs are designed to prevent enzymes accelerating, or 'catalysing', inappropriate reactions.

"Our research has shown at an atomic level how enzymes act as catalysts; the findings are a radical departure from the traditional view of how they work and might explain why attempts to make artificial enzymes have so far been disappointing.

The work - published as a major research article in the leading journal Science - builds on earlier studies by Professor Scrutton and Manchester colleagues, Professor Michael Sutcliffe and Dr David Leys.

Together they have shown, now in unprecedented detail, how enzymes avoid unfavourable energy barriers caused by the resistance to a reaction by allowing matter to 'flow through' the barrier - a process known as quantum mechanical tunnelling.

"We have provided new insight into how enzymes work from painstaking efforts of a large interdisciplinary group based on detailed experimental observations and theoretical analysis at the atomic level," said Professor Scrutton, who is based in the University's Faculty of Life Sciences.

"Modern drugs are designed to have structures that stick to enzymes and prevent them from catalysing the reactions, so our results need to be taken into account when designing new drugs.

"In the longer term, this research could also help us exploit enzymes more successfully and lead to better manufacturing processes in a number of commercial sectors.

"In cleaning products, for instance, enzymes help speed up the chemical reactions that break down protein and starch stains; a better understanding of how this process works could one day lead to more effective, faster acting agents."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The University of Manchester. (2019, June 19). Enzyme research points to better drugs and improved industrial processes. News-Medical. Retrieved on October 05, 2024 from https://www.news-medical.net/news/2006/04/25/17563.aspx.

  • MLA

    The University of Manchester. "Enzyme research points to better drugs and improved industrial processes". News-Medical. 05 October 2024. <https://www.news-medical.net/news/2006/04/25/17563.aspx>.

  • Chicago

    The University of Manchester. "Enzyme research points to better drugs and improved industrial processes". News-Medical. https://www.news-medical.net/news/2006/04/25/17563.aspx. (accessed October 05, 2024).

  • Harvard

    The University of Manchester. 2019. Enzyme research points to better drugs and improved industrial processes. News-Medical, viewed 05 October 2024, https://www.news-medical.net/news/2006/04/25/17563.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Immune cells could be new target to treat type 2 diabetes, hypertension in overweight people